Targetable signaling networks in idiopathic pulmonary fibrosis: from fibrotic modules to network-based therapeutic strategies

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal fibrosing interstitial lung disease characterized by irreversible extracellular matrix deposition, destruction of lung architecture, and progressive respiratory failure. A major challenge is that IPF is driven by interconnected molecular processes rather than a single pathogenic pathway, which may limit the effectiveness of pathway-restricted therapeutic strategies due to signaling redundancy, compensatory mechanisms, and feedback activation. This review addresses this challenge by integrating IPF-associated proteins by protein family, functional module, signaling pathway, and protein–protein interaction (PPI) relationships. This integrated framework identifies key regulatory hubs and convergence points linking epithelial injury, fibroblast activation, extracellular matrix remodeling, mechano-transduction, metabolic adaptation, oxidative stress, proteostasis, senescence, and immune remodeling. The analysis highlights a TGF-β-centered fibrotic core, alongside FAK–Rho/ROCK mechano-transduction, PI3K/AKT/mTOR metabolic-survival, NOX4–NRF2 redox, unfolded protein response, and immune-checkpoint modules. These modules show extensive signaling crosstalk and functional overlap, offering a systems-level view of how interconnected molecular processes may sustain fibrotic progression. The review further maps representative therapeutic strategies to these network hubs, distinguishing established treatments from preclinical candidates and clinical-stage interventions. Although direct experimental evidence showing that simultaneously targeting these major hubs outperforms single-node inhibition remains limited, the network framework supports investigating combinations that target complementary disease mechanisms. Overall, this review highlights the interconnected molecular mechanisms underlying IPF and suggests potential targets for future combination therapies and precision medicine.

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2026-11-13
DOI
https://doi.org/10.1186/s10020-026-01682-3
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Targetable signaling networks in idiopathic pulmonary fibrosis: from fibrotic modules to network-based therapeutic strategies

Khushnuma Wahabi, Sumbul Afreen, Anas Shamsi, Sukhwinder Singh Sohal et al.
1 links
Molecular Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Targetable signaling networks in idiopathic pulmonary fibrosis: from fibrotic modules to network-based therapeutic strategies

Khushnuma Wahabi, Sumbul Afreen, Anas Shamsi, Sukhwinder Singh Sohal, Nida Mubin, Mohd Sahil Hasmi, Md. Imtaiyaz Hassan, Khuzin Dinislam
article en

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal fibrosing interstitial lung disease characterized by irreversible extracellular matrix deposition, destruction of lung architecture, and progressive respiratory failure. A major challenge is that IPF is driven by interconnected molecular processes rather than a single pathogenic pathway, which may limit the effectiveness of pathway-restricted therapeutic strategies due to signaling redundancy, compensatory mechanisms, and feedback activation. This review addresses this challenge by integrating IPF-associated proteins by protein family, functional module, signaling pathway, and protein–protein interaction (PPI) relationships. This integrated framework identifies key regulatory hubs and convergence points linking epithelial injury, fibroblast activation, extracellular matrix remodeling, mechano-transduction, metabolic adaptation, oxidative stress, proteostasis, senescence, and immune remodeling. The analysis highlights a TGF-β-centered fibrotic core, alongside FAK–Rho/ROCK mechano-transduction, PI3K/AKT/mTOR metabolic-survival, NOX4–NRF2 redox, unfolded protein response, and immune-checkpoint modules. These modules show extensive signaling crosstalk and functional overlap, offering a systems-level view of how interconnected molecular processes may sustain fibrotic progression. The review further maps representative therapeutic strategies to these network hubs, distinguishing established treatments from preclinical candidates and clinical-stage interventions. Although direct experimental evidence showing that simultaneously targeting these major hubs outperforms single-node inhibition remains limited, the network framework supports investigating combinations that target complementary disease mechanisms. Overall, this review highlights the interconnected molecular mechanisms underlying IPF and suggests potential targets for future combination therapies and precision medicine.

Molecular Medicine
University of Tasmania (AU), Ajman University (AE), Launceston General Hospital (AU), Bashkir State Medical University (RU), Case Western Reserve University (US), Jamia Millia Islamia (IN), Indian Institute of Technology Delhi (IN), RMIT University (AU)
Indian Council of Medical Research
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon